| EVIDENCE
WATCH A review and assessment of recent
clinical trial data
GI stromal
tumour
PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED
TRIAL OF SU11248 IN PATIENTS (PTS) FOLLOWING FAILURE OF IMATINIB
FOR METASTATIC GIST (ABSTRACT 4000).
Breast
cancer
DO STATINS REDUCE BREAST CANCER RISK? A CASE CONTROL STUDY
IN US FEMALE VETERANS.
|